American Hospital Association
July 2, 2021
We are pleased that the U.S. Supreme Court has agreed to hear the compelling arguments in our case on payments cuts to the 340B drug pricing program that are adversely impacting care to patients. We are hopeful that the Court will reject the appellate court decision deferring to the government’s interpretation of the law that clearly imperils the important services that the 340B program helps allow eligible hospitals and health systems to provide to vulnerable communities, many of which would otherwise be unavailable.
Contact: Colin Milligan, (202) 638-5491, email@example.com
Marie Johnson, (202) 626-2351, firstname.lastname@example.org